טוען...
Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?
The concept of applying all active therapeutic agents in Total Therapy (TT) clinical trials for newly diagnosed multiple myeloma was pursued with the intent of developing curative treatment. The results of TT1 (n = 231), TT2 (n = 668) without or with thalidomide and TT3 with added bortezomib (n = 30...
שמור ב:
| Main Authors: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3744094/ https://ncbi.nlm.nih.gov/pubmed/22705990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2012.160 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|